title: Assessing the cellular transmembrane electrical potential difference on the hepatic uptake of palmitate.
abstract: Understanding the driving forces for the hepatic uptake of endogenous and exogenous substrates in isolated cells and organs is fundamental to describing the underlying hepatic physiology/pharmacology. In this study we investigated whether uptake of plasma protein-bound [3H]-palmitate across the hepatocyte wall is governed by the transmembrane electrical potential difference (PD). Uptake was studied in isolated hepatocytes and isolated perfused rat livers (IPL). Protein-binding and vasoactive properties of the different perfusates were determined using in vitro heptane/buffer partitioning studies and the multiple indicator dilution (MID) technique in the IPL, respectively. Altering hepatocyte PD by perfusate ion substitution resulted in either a substantial depolarization (-14 +/- 1 mV, n = 12, mean +/- S.E., substituting choline for Na+) or hyperpolarization (-46 +/- 3 mV, n = 12, mean +/- S.E., substituting nitrate for Cl-). Perfusate ion substitution also affected the equilibrium binding constant for the palmitate-albumin complex. IPL studies suggested that, other than with gluconate buffer, hepatic [3H]-palmitate extraction was not affected by the buffer used, implying PD was not a determinant of extraction. [3H]-Palmitate extraction was much lower (p < 0.05) when gluconate was substituted for Cl- ion. This work contrasts with that for the extraction of [3H]-alanine where hepatic extraction fraction was significantly reduced during depolarization. Changing the albumin concentration did not affect hepatocyte PD, and [3H]-palmitate clearance into isolated hepatocytes was not affected by the buffers used. MID studies with vascular and extravascular references revealed that, with the gluconate substituted buffer, the extravascular volume possibly increased the diffusional path length thus explaining reduced [3H]-palmitate extraction fraction in the IPL.
authors.affiliation: Faculty of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada. burczyn@cc.umanitoba.ca
authors.forename: F J
authors.initials: FJ
authors.lastname: Burczynski
authors.forename: D
authors.initials: D
authors.lastname: Hung
authors.forename: G Q
authors.initials: GQ
authors.lastname: Wang
authors.forename: B
authors.initials: B
authors.lastname: Elmadhoun
authors.forename: A
authors.initials: A
authors.lastname: Lewis
authors.forename: P
authors.initials: P
authors.lastname: Chang
authors.forename: G
authors.initials: G
authors.lastname: Rajaraman
authors.forename: S
authors.initials: S
authors.lastname: Robert
mesh_terms: D000409:Alanine / Q000737:chemistry; D000818:Animals; D002021:Buffers; D002713:Chlorine / Q000378:metabolism; D005942:Gluconates / Q000737:chemistry; D022781:Hepatocytes / Q000378:metabolism; D007477:Ions; D008024:Ligands; D008099:Liver / Q000378:metabolism*; D008297:Male; D008564:Membrane Potentials; D008566:Membranes / Q000378:metabolism; D010168:Palmitates / Q000493:pharmacokinetics*; D019308:Palmitic Acid / Q000378:metabolism; D010477:Perfusion; D011485:Protein Binding; D051381:Rats; D017207:Rats, Sprague-Dawley; D013997:Time Factors
chemical_list: D002021:Buffers; D005942:Gluconates; D007477:Ions; D008024:Ligands; D010168:Palmitates; D019308:Palmitic Acid; D002713:Chlorine; D000409:Alanine; C030691:gluconic acid